J Pharmacoepidemiol Risk Manage.  2022 Sep;14(2):165-168. 10.56142/jperm.22.0013.

A Case of Atypical Fixed Drug Eruption Induced by Erdosteine

Affiliations
  • 1College of Pharmacy, Seoul National University, Seoul, Korea
  • 2Seoul National University Hospital Drug Safety Monitoring Center, Seoul, Korea
  • 3Seoul National University Hospital Regional Pharmacovigilance Center, Seoul, Korea
  • 4Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

Abstract

Erdosteine is a mucolytic agent used in acute and chronic respiratory disease and it is known to be well tolerated. Adverse drug reactions related with erdosteine are mostly mild gastrointestinal symptoms and only two case reports of hypersensitivity have been published. Here, we report a case of atypical fixed drug eruption related with erdosteine intake proven by a drug provocation test. Physicians should be aware of the hypersensitivity reaction related to erdosteine, despite its well-known tolerability.

Keyword

Expectorants; Drug hypersensitivity; Drug-related side effects and adverse reactions
Full Text Links
  • JPERM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr